Literature DB >> 27301931

The phospholipid flippase ATP8B1 mediates apical localization of the cystic fibrosis transmembrane regulator.

Vincent A van der Mark1, Hugo R de Jonge2, Jung-Chin Chang1, Kam S Ho-Mok1, Suzanne Duijst1, Dragana Vidović3, Marianne S Carlon3, Ronald P J Oude Elferink1, Coen C Paulusma4.   

Abstract

Progressive familial intrahepatic cholestasis type 1 (PFIC1) is caused by mutations in the gene encoding the phospholipid flippase ATP8B1. Apart from severe cholestatic liver disease, many PFIC1 patients develop extrahepatic symptoms characteristic of cystic fibrosis (CF), such as pulmonary infection, sweat gland dysfunction and failure to thrive. CF is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR), a chloride channel essential for epithelial fluid transport. Previously it was shown that CFTR transcript levels were strongly reduced in livers of PFIC1 patients. Here we have investigated the hypothesis that ATP8B1 is important for proper CFTR expression and function. We analyzed CFTR expression in ATP8B1-depleted intestinal and pulmonary epithelial cell lines and assessed CFTR function by measuring short-circuit currents across transwell-grown ATP8B1-depleted intestinal T84 cells and by a genetically-encoded fluorescent chloride sensor. In addition, we studied CFTR surface expression upon induction of CFTR transcription. We show that CFTR protein levels are strongly reduced in the apical membrane of human ATP8B1-depleted intestinal and pulmonary epithelial cell lines, a phenotype that coincided with reduced CFTR activity. Apical membrane insertion upon induction of ectopically-expressed CFTR was strongly impaired in ATP8B1-depleted cells. We conclude that ATP8B1 is essential for correct apical localization of CFTR in human intestinal and pulmonary epithelial cells, and that impaired CFTR localization underlies some of the extrahepatic phenotypes observed in ATP8B1 deficiency.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ATP8B1; CFTR; Chloride transport; Cystic fibrosis; PFIC1; Trafficking

Mesh:

Substances:

Year:  2016        PMID: 27301931     DOI: 10.1016/j.bbamcr.2016.06.005

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  Specific stabilization of CFTR by phosphatidylserine.

Authors:  Ellen Hildebrandt; Netaly Khazanov; John C Kappes; Qun Dai; Hanoch Senderowitz; Ina L Urbatsch
Journal:  Biochim Biophys Acta Biomembr       Date:  2016-11-30       Impact factor: 3.747

2.  Matrix Metalloproteinase 7 Expression and Apical Epithelial Defects in Atp8b1 Mutant Mouse Model of Pulmonary Fibrosis.

Authors:  Emma Westermann-Clark; Ramani Soundararajan; Jutaro Fukumoto; Sahebgowda Sidramagowda Patil; Timothy M Stearns; Smita Saji; Alexander Czachor; Helena Hernandez-Cuervo; Mason Breitzig; Sudarshan Krishnamurthy; Richard F Lockey; Narasaiah Kolliputi
Journal:  Biomolecules       Date:  2022-02-09

3.  Clinical phenotype of adult-onset liver disease in patients with variants in ABCB4, ABCB11, and ATP8B1.

Authors:  Jeremy S Nayagam; Pierre Foskett; Sandra Strautnieks; Kosh Agarwal; Rosa Miquel; Deepak Joshi; Richard J Thompson
Journal:  Hepatol Commun       Date:  2022-07-27

4.  Disruption of Tmem30a results in cerebellar ataxia and degeneration of Purkinje cells.

Authors:  Yeming Yang; Kuanxiang Sun; Wenjing Liu; Lin Zhang; Kun Peng; Shanshan Zhang; Shujin Li; Mu Yang; Zhilin Jiang; Fang Lu; Xianjun Zhu
Journal:  Cell Death Dis       Date:  2018-09-05       Impact factor: 8.469

5.  Distinctive lipid signatures of bronchial epithelial cells associated with cystic fibrosis drugs, including Trikafta.

Authors:  Nara Liessi; Emanuela Pesce; Clarissa Braccia; Sine Mandrup Bertozzi; Alessandro Giraudo; Tiziano Bandiera; Nicoletta Pedemonte; Andrea Armirotti
Journal:  JCI Insight       Date:  2020-08-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.